Science News

... from universities, journals, and other research organizations

Enzyme's Cancer-Promoting Activities Linked To Inactivation Of 'Genome Guardian'

Oct. 16, 2007 — The enzyme WIP1 (wild-type p53-induced phosphatase one) becomes cancer-causing when there is too much of it, preventing the p53 gene from protecting the genome against dangerous DNA mutations, said Baylor College of Medicine researchers in a report that appears in the journal Cancer Cell.


Share This:

The gene p53 prevents a damaged or stressed cell from dividing, said Dr. Lawrence A. Donehower, professor of molecular virology and microbiology and molecular and cellular biology at BCM. When these damaged cells cannot reproduce, they cannot repeat the genetic changes that have led to their damage. In the research described in this report, he and his colleagues describe how WIP1 interacts with both p53 and its off-switch, a protein called Mdm2.

"In the cell, p53 helps to repair cell damage by eliminating those cells with damaged or mutated DNA," said Donehower. "Once that task is accomplished, Mdm2 builds up and turns off p53, bringing the situation back to normal."

"After p53 has finished its activity, WIP1 removes a phosphate molecule, which allows Mdm2 to degrade the p53," said Donehower. However, when WIP1 is overexpressed, meaning there is extra enzyme in the cell, it stabilizes Mdm2, increasing the rate of p53 degradation.

The fact that WIP1 is increased in some breast, ovarian and brain tumors buttresses its role in causing cells to become cancerous, said Donehower.

"In some tumor types, if you have WIP1 overexpression, the prognosis is poorer than if you don't," he said. In fact, tumors with high levels of WIP1 rarely have mutations in p53, he said.

"If you have a lot of this protein in the cell, it's continually knocking down p53. The tumor doesn't need to mutate the p53 gene," he said.

Others who took part in this research include Xiongbin Lu, Ou Ma and Thuy-Ai Nguyen, all of BCM, Stephen N. Jones of the University of Massachusetts Medical School in Worcester, and Moshe Oren of the Weizmann Institute in Rehovot, Israel.

Funding for this research came from the National Institutes of Health, the A-T Children's Project and the U.S. Department of Defense Breast Cancer Research Program.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by Baylor College Of Medicine.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 138,568

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
Interested in ad-free access? If you'd like to read ScienceDaily without ads, let us know!
  more breaking science news

Social Networks


Follow ScienceDaily on Facebook, Twitter,
and Google:

Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

  • more science news

In Other News ...

  • more top news

Science Video News


Doggy Genes

Molecular biologists have completely sequenced the first dog genome. Understanding how genetics plays a role in canine diseases could lead to new. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: